GILD - naturally cooling

Gilead Sciences (GILD) continues to be under s/t downward pressure, settling -2.5% at $77.88. After a run from the $62s to the $85s, some cooling to the 72/71s would be very natural indeed. M/T bullish >90, with a grander target of $110. L/T >150.


GILD daily

GILD monthly

Summary

Suffice to add... GILD is my favourite health/bio stock.
--

Based on latest earnings and a stock price in AH of the $75s, forward price earnings multiple: 8/7s, with a yield of around 2.8%. On any basis, that is a ludicrously low valuation.

Seen on a giant multi-year chart, price structure across the last few months is a bull flag. It will be provisionally confirmed with a break >85.73. Basic target is the $90 threshold, and then $110, which seems viable by mid 2018.

To be clear, I am s/t bearish the stock, but m/t hyper bullish.